by Clinical Neuropsychologist | Thursday, May 30, 2024 | Dementia
Abstract INTRODUCTION Recent genome-wide association studies (GWAS) have reported a genetic association with Alzheimer’s disease (AD) at the TNIP1/GPX3 locus, but the mechanism is unclear. METHODS We used cerebrospinal fluid (CSF) proteomics data to test...
by Clinical Neuropsychologist | Wednesday, May 29, 2024 | Dementia
Abstract INTRODUCTION We examined whether hypertension (HTN) was associated with Alzheimer’s disease-related biomarkers in cerebrospinal fluid (CSF) and how changes in blood pressure (BP) related to changes in CSF biomarkers over time. METHODS A longitudinal...
by Clinical Neuropsychologist | Wednesday, May 29, 2024 | Dementia
Abstract INTRODUCTION Informant reports are a critical component of dementia diagnoses, but the comparability of informant reports across countries is not well understood. METHODS We compared the performance of the Informant Questionnaire on Cognitive Decline in the...
by Clinical Neuropsychologist | Wednesday, May 29, 2024 | Dementia
Abstract BACKGROUND We examined spatial patterns of brain atrophy after mild, moderate, and severe traumatic brain injury (TBI), the relationship between progression of brain atrophy with initial traumatic axonal injury (TAI), cognitive outcome, and with serum...
by Clinical Neuropsychologist | Monday, May 27, 2024 | Dementia
Abstract INTRODUCTION While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care. METHODS In 2023, the Alzheimer’s Association hosted...
